Engineering Insights
Vendor:
First CVE: Jan 8, 2021 · Active for 5 years
22
Total CVEs
More Total CVEs than 94% of tracked products
22.0
Avg CVEs / Year
Higher CVE frequency than 98% of tracked products
5.4
Avg CVSS
Higher Avg CVSS than 14% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Engineering Insights over time
Volume of CVEsAvg CVSS Base Score
First CVE
Jan 8, 2021
5 years ago
Most Recent CVE
Apr 12, 2021
1,931 days ago
CVE Severity & Scoring
Engineering Insights22 CVEs
91%
9%
All CVEs352,719 CVEs
45%
40%
11%
MediumHigh
Attack Vector
Local0 (0.0%)
Network22 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low22 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None5 (22.7%)
Unknown0 (0.0%)
Required17 (77.3%)
Privileges Required
Low21 (95.5%)
High0 (0.0%)
None1 (4.5%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (22 CVEs).
22 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2021-20502HIGH IBM Jazz Foundation Products are vulnerable to an XML External Entity Injection (XXE) attack when processing XML data. A remote attacker could exploit this vulnerability to expose | Mar 30, 2021 | 7.1 | 23 | NO | NO |
CVE-2021-20504MEDIUM IBM Jazz Foundation Products are vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended fun | Mar 30, 2021 | 5.4 | 20 | NO | NO |
CVE-2021-20503MEDIUM IBM Jazz Foundation Products are vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended fun | Mar 30, 2021 | 5.4 | 20 | NO | NO |
CVE-2021-20352MEDIUM IBM Jazz Foundation Products are vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended fun | Mar 30, 2021 | 5.4 | 20 | NO | NO |
CVE-2020-4733MEDIUM IBM Jazz Foundation products are vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended fun | Jan 8, 2021 | 5.4 | 20 | NO | NO |
CVE-2020-4691MEDIUM IBM Jazz Foundation Products are vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended fun | Jan 8, 2021 | 5.4 | 20 | NO | NO |
CVE-2020-4965HIGH IBM Jazz Team Server products use weaker than expected cryptographic algorithms that could allow an attacker to decrypt highly sensitive information. IBM X-Force ID: 192422. | Apr 12, 2021 | 7.5 | 19 | NO | NO |
CVE-2021-20520MEDIUM IBM Jazz Foundation Products are vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended fun | Mar 30, 2021 | 5.4 | 19 | NO | NO |
CVE-2021-20518MEDIUM IBM Jazz Foundation Products are vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended fun | Mar 30, 2021 | 5.4 | 19 | NO | NO |
CVE-2021-20506MEDIUM IBM Jazz Foundation Products are vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended fun | Mar 30, 2021 | 5.4 | 19 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (22 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (22 CVEs).
Media Mentions
Signals from CVEs in this product scope (22 CVEs).
Top CNAs Publishing CVEs For Engineering Insights
Top CWEs
Versions
| Version | CVE Count | Avg CVSS | Avg EPSS | KEV | Exploits |
|---|---|---|---|---|---|
| 7.0.2 | 12 | 5.6 | 0.6% | 0 | 0 |
| 7.0.1 | 17 | 5.4 | 0.7% | 0 | 0 |
| 7.0.0 | 4 | 5.7 | 0.7% | 0 | 0 |
| 7.0 | 18 | 5.4 | 0.7% | 0 | 0 |